Eszopiclone in the Treatment of Insomnia and Fibromyalgia
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose is to assess the efficacy of eszopiclone for the treatment of insomnia and other
symptoms of fibromyalgia. It is hypothesized that participants receiving eszopiclone will
report greater improvement in total sleep time, sleep quality, pain, fatigue, physical
functioning, and emotional distress than will those receiving placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Lesley A. Allen, Ph.D. University of Medicine and Dentistry of New Jersey